1.
Prehabilitation for Bariatric Surgery: A Randomized, Controlled Trial Protocol and Pilot Study.
García-Delgado, Y, López-Madrazo-Hernández, MJ, Alvarado-Martel, D, Miranda-Calderín, G, Ugarte-Lopetegui, A, González-Medina, RA, Hernández-Lázaro, A, Zamora, G, Pérez-Martín, N, Sánchez-Hernández, RM, et al
Nutrients. 2021;(9)
Abstract
Bariatric surgery is the most efficacious treatment for obesity, though it is not free from complications. Preoperative conditioning has proved beneficial in various clinical contexts, but the evidence is scarce on the role of prehabilitation in bariatric surgery. We describe the protocol and pilot study of a randomized (ratio 1:1), parallel, controlled trial assessing the effect of a physical conditioning and respiratory muscle training programme, added to a standard 8-week group intervention based on therapeutical education and cognitive-behavioural therapy, in patients awaiting bariatric surgery. The primary outcome is preoperative weight-loss. Secondary outcomes include associated comorbidity, eating behaviour, physical activity, quality of life, and short-term postoperative complications. A pilot sample of 15 participants has been randomized to the intervention or control groups and their baseline features and results are described. Only 5 patients completed the group programme and returned for assessment. Measures to improve adherence will be implemented and once the COVID-19 pandemic allows, the clinical trial will start. This is the first randomized, clinical trial assessing the effect of physical and respiratory prehabilitation, added to standard group education and cognitive-behavioural intervention in obese patients on the waiting list for bariatric surgery. Clinical Trial Registration: NCT0404636.
2.
Obesity and SARS-CoV-2: Considerations on bariatric surgery and recommendations for the start of surgical activity.
Sánchez Santos, R, Garcia Ruiz de Gordejuela, A, Breton Lesmes, I, Lecube Torelló, A, Moizé Arcone, V, Arroyo Martin, JJ, Fernandez Alsina, E, Martín Antona, E, Rubio Herrera, MÁ, Sabench Pereferrer, F, et al
Cirugia espanola. 2021;(1):4-10
-
-
Free full text
-
Abstract
The SARS-CoV-2 pandemic has a great impact worldwide, being Spain one of the most affected countries. The delay in bariatric surgery can have fatal consequences since up to 50% of the patients who are on the waiting list develop a new comorbidity during the time they remain on it and 1.5% of patients die while waiting for the intervention. That is why bariatric surgery should not be delayed, if the occupation of the hospital by COVID-19+ patients decreases significantly, and sufficient resources and safety are available to restart surgery in patients with benign pathology. This document contains the main recommendations for the bariatric surgery programs in our country from the point of view of safety, bariatric patient preparation and follow up during the SARS-CoV-2 pandemia.